Detalles de la búsqueda
1.
Multimodal prediction of neoadjuvant treatment outcome by serial FDG PET and MRI in women with locally advanced breast cancer.
Breast Cancer Res
; 25(1): 138, 2023 11 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37946201
2.
The oral selective estrogen receptor degrader GDC-0810 (ARN-810) in postmenopausal women with hormone receptor-positive HER2-negative (HR + /HER2 -) advanced/metastatic breast cancer.
Breast Cancer Res Treat
; 197(2): 319-331, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36401732
3.
Fluorine-18-Labeled Fluoroestradiol PET/CT: Current Status, Gaps in Knowledge, and Controversies-AJR Expert Panel Narrative Review.
AJR Am J Roentgenol
; 2023 Dec 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-38117098
4.
18F-fluorodeoxyglucose (FDG) PET or 18F-fluorothymidine (FLT) PET to assess early response to aromatase inhibitors (AI) in women with ER+ operable breast cancer in a window-of-opportunity study.
Breast Cancer Res
; 23(1): 88, 2021 08 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-34425871
5.
Whole-Body Characterization of Estrogen Receptor Status in Metastatic Breast Cancer with 16α-18F-Fluoro-17ß-Estradiol Positron Emission Tomography: Meta-Analysis and Recommendations for Integration into Clinical Applications.
Oncologist
; 25(10): 835-844, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32374053
6.
Temporal Heterogeneity of Estrogen Receptor Expression in Bone-Dominant Breast Cancer: 18F-Fluoroestradiol PET Imaging Shows Return of ER Expression.
J Natl Compr Canc Netw
; 14(2): 144-7, 2016 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-26850484
7.
The use of stereotactic radiosurgery for brain metastases from breast cancer: who benefits most?
Breast Cancer Res Treat
; 149(3): 743-9, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25638395
8.
Effects of adjuvant exemestane versus anastrozole on bone mineral density for women with early breast cancer (MA.27B): a companion analysis of a randomised controlled trial.
Lancet Oncol
; 15(4): 474-82, 2014 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-24636210
9.
Trends in 5-year survival rates among breast cancer patients by hormone receptor status and stage.
Breast Cancer Res Treat
; 147(3): 609-16, 2014 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-25164974
10.
Alcohol, Smoking, and Risks of Breast Cancer Recurrence and Mortality among Women with Luminal, Triple-Negative, and HER2-Overexpressing Breast Cancer.
Cancer Epidemiol Biomarkers Prev
; 33(2): 288-297, 2024 02 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38019269
11.
Repeatability of 18F-FDG uptake in metastatic bone lesions of breast cancer patients and implications for accrual to clinical trials.
EJNMMI Res
; 14(1): 32, 2024 Mar 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-38536511
12.
Repeatability of 18F-FDG uptake in metastatic bone lesions of breast cancer patients and implications for accrual to clinical trials.
Res Sq
; 2024 Jan 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38313279
13.
Multicenter trials using ¹8F-fluorodeoxyglucose (FDG) PET to predict chemotherapy response: effects of differential measurement error and bias on power calculations for unselected and enrichment designs.
Clin Trials
; 10(6): 886-95, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-24169628
14.
Can Molecular Imaging Find a Path to Navigate Evolving Breast Cancer Treatments?
Clin Cancer Res
; 29(11): 2015-2016, 2023 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36988617
15.
Summary: Appropriate Use Criteria for Estrogen Receptor-Targeted PET Imaging with 16α-18F-Fluoro-17ß-Fluoroestradiol.
J Nucl Med
; 64(3): 351-354, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36863779
16.
Secondary Breast Angiosarcoma After a Primary Diagnosis of Breast Cancer: A Retrospective Analysis of the Surveillance, Epidemiology, and End Results (SEER) Database.
Am J Clin Oncol
; 46(12): 567-571, 2023 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37725702
17.
A Phase II Study Evaluating the Safety and Efficacy of Sunitinib Malate in Combination With Weekly Paclitaxel Followed by Doxorubicin and Daily Oral Cyclophosphamide Plus G-CSF as Neoadjuvant Chemotherapy for Locally Advanced or Inflammatory Breast Cancer.
Clin Breast Cancer
; 22(1): 32-42, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34158245
18.
AMEERA-1 phase 1/2 study of amcenestrant, SAR439859, in postmenopausal women with ER-positive/HER2-negative advanced breast cancer.
Nat Commun
; 13(1): 4116, 2022 07 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-35840573
19.
Determinants of Guideline-Discordant Breast Cancer Care.
Cancer Epidemiol Biomarkers Prev
; 30(1): 61-70, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33093159
20.
18F-Fluoroestradiol PET Imaging in a Phase II Trial of Vorinostat to Restore Endocrine Sensitivity in ER+/HER2- Metastatic Breast Cancer.
J Nucl Med
; 62(2): 184-190, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-32591490